Latest Breaking News On - Biotechnology corporation the company - Page 1 : vimarsana.com

PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study Endpoints in First Line Recurrent/Metastatic HPV16-Positive Head and Neck Cancer

PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study Endpoints in First Line Recurrent/Metastatic HPV16-Positive Head and Neck Cancer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMike moyerGina mangiaracinaBiotechnology corporation nasdaqBiotechnology corporationUnited states securities exchangeMerck co incExchange commissionBiotechnology corporation the companyTrial meets primary study endpointsFirst linePositive headKey opinion leaderCombined positive scoreUnited states securities exchange actUnited states securities act

PDS Biotechnology Announces Details of Virtual KOL Event

PDS Biotechnology Announces Details of Virtual KOL Event
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

University of north carolinaNorth carolinaUnited statesNew yorkDana farber cancer instituteUniversity of marylandSaint josephGina mangiaracinaMike moyerJared weissKirk shepardRobert haddadAmerican association for cancer researchNeck society meetingLung cancer initiative of north carolinaBiotechnology corporation

PDS Biotechnology : Biotech Announces Publication of Preclinical Research and Grant of U S Composition of Matter Patent for Infectimune® - Form 8-K -March 13, 2024 at 06:08 am EDT

PDS Biotech Announces Publication of Preclinical Research and Grant of U.S. Composition of Matter Patent for Infectimune® .

United statesBiotechnology corporation the companyUnited states securities exchangeExchange commissionUnited states securities exchange actUnited states securities actFinancial condition

PDS Biotech Announces Retirement of Lauren V Wood, M D , and Appointment of Kirk V Shepard, M D , as Chief Medical Officer - PDS Biotechnology (NASDAQ:PDSB)

PRINCETON, N.J., Jan. 22, 2024 (GLOBE NEWSWIRE) PDS Biotechnology Corporation (NASDAQ:PDSB) ("PDS Biotech" or "the Company"), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer

United statesGina cestariLaurenv woodFrank beduKirk shepardKirkv shepardUniversity of cincinnati medical schoolGlobal medical affairs at takeda pharmaceuticals internationalDepartment of hematologyBiotechnology corporation the companyGlobal medical affairs at baxter international incExchange commissionScientific affairs at boehringer ingelheim pharmaceuticals incBiotechnology corporationCase western reserve universityCornell university

PDS Biotech Announces Retirement of Lauren V Wood, M D , and Appointment of Kirk V Shepard, M D , as Chief Medical Officer

PDS Biotech Announces Retirement of Lauren V Wood, M D , and Appointment of Kirk V Shepard, M D , as Chief Medical Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesGina cestariKirkv shepardLaurenv woodFrank beduKirk shepardExchange commissionCornell universityGlobal medical affairs at baxter international incAffairs professional societyCase western reserve universityBiotechnology corporation the companyMerck co incDepartment of hematologyUniversity of chicago hospitalsScientific affairs at boehringer ingelheim pharmaceuticals inc